Access this stock data via API
Subscribe
PentixaPharm Holding AG
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 79K 19K 19K 118K
Cost of revenue 1.9M 1.6M 1.2M 3.7M
Gross profit -1.9M -1.6M -1.2M -3.6M
Operating expense
Research & development
Selling general and admin
Other operating expenses 462K 924K 842K 1.1M
Operating income -4.6M -4.5M -4.1M -17.5M
Non operating interest income
Income 101K
Expense
Other income expense
Pretax income -4.4M -4.5M -4.1M -16.4M
Tax provision -91K -98K -98K -3.7M
Net income -4.3M -4.4M -4.0M -12.7M
Basic EPS -0.2 -0.2 -0.2
Diluted EPS -0.2 -0.2 -0.2
Basic average shares 24.8M 24.8M 24.8M
Diluted average shares 24.8M 24.8M 24.8M
EBITDA -3.6M -3.6M -3.1M 2.0M
Net income from continuing op. -4.3M -4.4M -4.0M -12.7M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 26 minutes

00:33
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).